PharmaShots | Incisive News in 3 Shots

Subscribe Now

Arvinas

Arvinas Collaborates with Novartis to Develop and Commercialize ARV-766 for Treating Prostate Cancer

Arvinas Collaborates with Novartis to Develop and Commercialize ARV-766 for Treating Prostate Cancer

April 11, 2024

Arvinas Reports Results of ARV-471 in P-I/II Study for the Treatment of Breast Cancer

Arvinas Reports Results of ARV-471 in P-I/II Study for the Treatment of Breast Cancer

November 23, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us